Hypercalcemia may develop both spontaneously and as a result of androgen therapy in women with disseminated breast carcinoma. If it develops while on this agent, the drug should be discontinued. Caution is required in administering these agents to patients with cardiac, renal or hepatic disease. Cholestatic jaundice is associated with therapeutic use of anabolic and androgenic steroids. Edema may occur occasionally with or without congestive heart failure. Concomitant administration of adrenal steroids or ACTH may add to the edema. In children, anabolic steroid treatment may accelerate bone maturation without producing compensatory gain in linear growth. This adverse effect may result in compromised adult stature. The younger the child the greater the risk of compromising final mature height. The effect on bone maturation should be monitored by assessing bone age of the wrist and hand every six months. This drug has not been shown to be safe and effective for the enhancement of athletic performance. Because of the potential risk of serious adverse health effects, this drug should not be used for such purpose.
An effective dosage of Sustanon ranges from 250mg a week to 1000mg per week. Although Sustanon remains active in the body for approximately three weeks, injections are taken at least every 10 days. Sustanon stacks extremely well with potent orals like Anadrol and Anabol , but it might work better with Trenbolone or Winstrol if the athlete is seeking to maintain a harder, more defined look to his physique. Many individuals like to use a combination of Nolvadex & Proviron , while others use an anti-aromatase like Arimidex , Femara, or Aromasin, to help control estrogen related effects. The main side effects of Sustanon are: headache, depression, aggression, anxiety, sleep disorders, numbness, acne, aggressiveness, sexual overstimulation, oily skin, accelerated hair loss, and reduced production of the body's own hormones, nausea, cholestatic jaundice and possible liver damage.